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ABSTRACT 
Because the thymus expresses the natriuretic peptides (NP) as well 
as their respective receptors, an involvement of NP in the physiology 
of this organ has been suggested. To evaluate functional aspects of NP 
in the thymus, we looked for thymic cells bearing NP receptors (Npr). 
Furthermore, the regulation of Npr expression by activation of cells 
and the influence of NP on the proliferation of thymocytes was stud- 
ied. Expression of receptor messenger RNAs CmRNAs) was examined 
by PCR and Northern blot. Existence of functional Npr was confirmed 
by measurement of cGMP, the second messenger of NP. Proliferation 
of thymocytes upon concanavalin A (Con A) stimulation was analyzed 
by incorporation of [“Hlthymidine. We report here that thymocytes 
H ORMONES and neuropeptides are potent immuno- modulators acting on various immune competent 
cells (for review see Refs. 1,2). It is well documented that the 
thymus, where bone marrow-derived precursor cells prolif- 
erate and differentiate to mature T-lymphocytes, is under 
endocrine control (3, 4). The regulation of these processes 
appears to be extremely complex (5). In addition to circu- 
lating hormones affecting these functions, complete neu- 
ropeptide systems exist involving synthesis of peptides and 
expression of their respective receptors by thymic cells (3). 
For example, GH, PRL, oxcytocin (OT), arginine-vasopressin 
(AVP), or p-endorphin are likely to control thymus physi- 
ology via paracrine and autocrine mechanisms in addition to 
the classical endocrine pathway (3, 6-9). 
Our previous work as well as data from others (10-13) 
implicate the natriuretic peptides (NP) in thymus regulation. 
This peptide family consists of atria1 natriuretic peptide 
(ANP), brain natriuretic peptide (BNP), and C-type natri- 
uretic peptide (CNP) and affects regulation of cardiovascular 
homeostasis (14-16). ANP and BNP are produced predom- 
inantly by the heart atrium and ventricle and act mainly as 
circulating hormones (14-16). In contrast, CNP is the major 
NP in the central nervous system (15,16). However, it is also 
synthesized by endothelial cells and seems to function as a 
local vascular regulator (15, 16, 17). Most of the biological 
actions of NP are thought to be mediated by two guanylyl 
cyclase-linked receptor subtypes (Npra and Nprb) with dif- 
ferent ligand selectivities (18). The Npra receptor is activated 
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express mRNAs for the three Npr, namely Npra, Nprb, and Nprc and 
that activation of Npra and Nprb increases cGMP levels. Stimulation 
of thymocytes with Con A (1 pg/ml, 48 h) resulted in an increase of 
mRNA coding for Npra, the receptor specific for atria1 natriuretic 
peptide (ANP) and brain natriuretic peptide. Nprb and Nprc receptor 
expression was not altered under these conditions. In agreement with 
these data only ANP, but not the C-type natriuretic peptide, elicited 
increased cGMP response in Con A-stimulated cells. ANP inhibited 
also the proliferation of Con A stimulated thymocytes, whereas C-type 
natriuretic peptide did not show this effect. These results suggest that 
ANP affects the complex mechanisms of thymocyte proliferation and 
differentiation. (Endocrinology 137:1706-1713, 1996) 
by ANP and BNP, whereas CNP is considered to be the 
specific ligand of the Nprb receptor (16, 18, 19). cGMP is 
thought to act as the second messenger (18,19). All three NP 
bind to the C-type receptor (Nprc). This type of receptor lacks 
guanylate cyclase activity and elicits clearance function of the 
NP (19, 20). 
We showed recently that all three NP are produced by the 
rat thymus (11). Expression of the thymic NP is regulated by 
different mechanisms because involution of this organ 
caused by dexamethasone or x-ray increases ANP but not 
BNP and CNP production (11,21,22). The detection of mes- 
senger RNA (mRNA) transcripts for all three NP receptors in 
the thymus (11) suggests the existence of a local NP system 
that may intrathymically modulate immune functions. 
The aim of the present study was to investigate NP re- 
ceptor expression on thymic cells and functional aspects of 
NP/ NP-receptor interaction. Thymocytes have been exam- 
ined for the corresponding Npr messenger RNAs (mRNAs) 
as well as for their guanylate cyclase response upon exposure 
to NP. In a second set of experiments, alterations of Npr 
expression by immunological stimuli as the mitogen Con- 
cavalin A (Con A) was evaluated. 
Materials and Methods 
Cell preparation and culture condition 
Rats (Sprague Dawley, male, 100 g) were decapitated, and the thymi 
quickly removed and either employed for RNA extraction or for isola- 
tion of thymocytes. Thymocytes were isolated as described (10) and 
purified by means of Ficoll (Pharmacia, Freiburg, Germany) gradient 
centrifugation. Identity and homogeneity of the isolated cell population 
were assessed by staining cells with a monoclonal mouse antirat thy- 
mocyte antigen Thy 1.1 antibody (Serotec Camon, Heidelberg, Ger- 
many) and a secondary fluorescein isothiocyanate-labeled antimouse 
IgG (Becton Dickinson, Heidelberg, Germany). Cells were then submit- 
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ted to flow cytometry (FACScan, Becton Dickinson), and data WEW 
e\prcss~‘d in 4 log~~rlthmic mode bzcd on dn accumulation of 10,000 
CC~IIS. 
As pwitivt’ control for receptor mRNA expression as well as cGM1’ 
response, C-6 rat glionia cells trdnsfected \vith either the complcmcntnry 
DNA (cDNA) ot Npra or Nprh (wlls have been provided by Dr. Gerzer, 
Kiiln, Germany) ha\,e hccn employed in the same manner as thymocytc‘s. 
For somr cxpcrlments, thymocytcs ha\re been cultured. Thvmocytes 
(10” cells/ml) wcrc1 s~spcnded in RPM1 1640 medium contai&ng 10% 
FCS, L-glutamine (2 X 10 ’ M) and penicillin (100 U/ml)/streptomycin 
(100 pg/ml) (all from Gibco, Eggenstein, Ccrmany) and cultured in 
flaks (175 cm’, Crcincr, Solingcn, Germany) for 48 h (37C, 5% CO:). Con 
A (1 pg/ ml, Bwhrlngcr Mannhcim, Mannhcim, Germany) stimulation 
~vas conducted for -18 h. 
Before subjc>cting cells to any cxpenment, their viability w‘e c‘xam- 
ined bv cithcr trvpan hluc exclusion or FACS analysis ot cells stained 
\vith propidium aiodide (Sigma, Dciscnhofen, Germany). Only batches 
shmving d \,idbility of greater than 90 ‘% \verr included in the study. 
Analvsis of mRNA coding for Npr 
,r1/<,\‘,4 ~‘vtroc~~~~,r. Extraction of mRNA from cithcr thymocytes, C-6 cells, 
or \vhole thymus tissue was pcrtormed as previously described in detail 
(23). Briefly, total RNA \vat, isol,lted by the guanidlnium thiocyanate/ 
cctsium chloride method, and mRNA was purified by means of poly-dT 
,idwrption (I’olyATract kit, Promega, Germany). 
~-11S,4 s!/r11/rc+. mRNA (1 pg) was transcribe1 in cDNA as described 
hcfow (23). Spc’ci,71 attention \\‘a75 paid to evaluate the efficiency of the 
rc-1 c‘rsc’ transcription, i.1,. the qu‘lntitation of cDNA svnthesized. For thw 
purpose, 1 FCi of (tu-‘~P)cl~souyc]itidin~ triphosphntc (3000 Ciimmol, 
H,irtm,in Analytic, Hannovcr, Germany) was added to an aliquot of the 
rc,iction mix. Incorporated radioactivity was determined after separa- 
tion of free-lahclc>d dCTI’ using glass tiher filters (GFIB, Whatman, 
M,iidstone, UK). cDNA concentrations varied up to 100%. Therefore, 
cDNA concentrations of s;amplcs have bwn adjusted to 10 ng/pl before 
I’CR analysis. 
PiR or~rll!/si.s. PCR wds performed as described before (23). The following 
prlmcr pairs \verc‘ cniployed according to (24): N/pro (25) sense primer 
(third axon) 5’.AAGAGCCTGATAATCCTGAGTACT-3’; antisense 
primer (sixth cxon) 5’.TTCCAGGCTGGGTCCTCATTGTCA-3’. N/41 
(26) sc’nsc’ primer (third t‘xon) 5’.AACGGGCGCATTGTGTATATCT- 
GCGGC-3’, antiscnsc primer (sixth axon): S’-TTATCACAGGATGG- 
GTCGTCCAAGTCA-3’; Nj~rc- (27) sense primer (end of first cxon): 5’. 
ATCGTGCGCCACATCCAGGCCAGT-3’: antisense primer (fifth and 
si\th c’wn): 5’.TCCAAAGTAATCACCAATCTCCTGGGTACCCGC-3’; 
~l~crr,ildehyci~~-3-p~i~~sphatc dehydrogenase (GAPDH) according to 
(28): wnw primer 5’.TCCCTCAAGATTCTCAGCAA-3’; antisense 
5’.AGATCCACAACGGATACATT-3’. 
To each I’CR rC’action mixture 1 FCi (tr-“P)dCTI’ was added for 
quantitation of PCR products bv measuring incorporated radioactivity. 
Rt,ceptor transcripts \vcre ampfificd in 30 cycles of 1 min (Npra) or 0.4 
mln (Nprb, Nprc), dcnaturation at Y3C, annealing at 6OC (1 min) for 
Npr‘i, 61C (0.5 min) for Nprb and 55C (0.5 min) for Nprc and extension 
at 73C tar 2 min (Npr“) or 1 min (Nprb, Nprc). Aliquots (6 ~1) of the PCR 
products \vc’rc’ suhmittcd to PAGE (7.5% polyacrylamidc) and further 
idcntificd hv sllvc’r nitrate staining followed by exposure to x-ray films. 
Rt,lofia, ~l!~~?~~/~t~lli~lr~ c!f PCR /~rolll,c-ts. First, conditions for linear ampli- 
fic-,ltion \vt’rc cst~~blishcd for the Npm, Nprb, and Nprc as \vell as for 
G)\I’DH mRNA, respectively. Increasing amounts of initial cDNA tcm- 
pl‘ltc \vew ,~mplificd in 30 cvcles employing the pairs of primers de- 
scribed r7hovc. Furthermore, Increasing number of cycles (25-40) we‘re 
run \\*ith constant ,imounts of cDNA. 
For comp,~rison of mRNA expression of thr Npr, three different 
amounts ot cDNA that had hwn proven to be amplified within the linear 
range (SW aho\,c) \vcw subjected to I’CR. Equal cDNA content of sam- 
picas \vas demonstrated by running ‘1 PCR for mRNA amplification of the 
housckccping gc’w GAPDFI. 
After PAGE, the corresponding hands were cut into vials containing 
30”,, I I,(), and counted in d /%countc~r in the prescncc of scintillation fluid. 
In all PCR expc%mcnts, the prescnw of possible contaminants was 
chcckcd h\, control reactions in \vhich either cDNA was omitted or 
mRNA was added instead of cDNA. PCR experiments wcrc’ pertormcd 
employing three indepcndcnt RNA preparations of the thymocytcs. 
Two indcpendcnt RNA prep~~rations ~vcrc cmploycd from the thymus 
and one from the transfcctcd C-6 cells. Samples wc1rc subjcctcd to PCR 
in triplicates. Valws dre expressed ds mcdns ? 5n. Curves obtained from 
blotting radioactivity incorporated in the I’CR products JS ‘1 hlnction of 
the initial amount ot cDNA template wcrc evaluated by means of linear 
regression analvsis (95 ‘Y, contidwcc limits). 
Northern blot analysis 
mRNA corresponding to ahout 100 pg total RNA extracted from 
thymocytes was electrophortwd on a 1 9, ng‘irosc gel and tr,insfcrrcd to 
nylon membranes (Nytran N; Schlcichcr & Schiill, Dassc>I, Ccrmany). A\ 
a positive control, RNA from rrit lung tlssut’ was processed in the sarw 
manner. The blots were hybridized with J full Icngth human Nprc cDNA 
(gift tram Dr. Porter, Scios Nova, Inc., Mountain Vic\v, CA), and \lith 
1.2.kb fragments from the 5’ end of the rat Npra as \vc’II as of the rat Nprh 
cDNA (gift from Drs. Sch~tlz and Garbers, Uni\wsit!: of Texas, Dallas, 
TX). Linearized probes were lahclcd with [‘~P]tu-urldinetri~~~~os~~~~~~t~~ 
(100 FCi) using irr ilitr(I transcription technique (kit from Boehringcr 
Mannheim). Hybridizations wcrc performed overnight at 63C ‘1s dc- 
scribed elsewhere (10). Blots wc1rc Mashed \vith 0.1 x SSC in the prescncc 
of 0.1% SDS at room temperature (30 min) and at 63C (15 min) end 
exposed to x-ray films (-70C) for h-12 days. 
Measurement of cGMP leoels 
Thymocytes (lo”/ tube) either freshly isolated, cultured, or Con A- 
activated, and C-6 cells (positive control) wcw incubated in 200 ~1 
RPMI-1610 medium containing 0.5 mM isobutyl-I-meth~Ixanthine (Sig- 
ma, Deisenhofcn, Germany) for 5 min. This was followed by adminis- 
tration of increasing concentrations (10 “-10 ” hl) of cithcr rat ANI’ 
YY -126 (NovaBiochcm, Bad Soden, Germanv), rat CNI’ I-22 (Peninsula, 
Heidelberg, Germany) or rat (de-Gln’“, Ser.“‘, Gly”‘, Lcu”, CIy”)-ANF 
4-23.NH, (C-ANF, Sigma, Deiscnhofcn, C&man\,) br 1 h at 37C, 5”<, 
CO:. Cells \verc‘ spurn do\vn (300 X ,y, IO min, 1C); the supernat,int \vds 
collected, boiled for 3 min, and ccntrifugcd (12,000 X ,\‘, 10 min). cGMP 
concentrations of supernatants ww measured dirt.ctly hy dn RIA (29). 
Cell proliferation assay 
Proliferation of thvmocytes \~a5 dct~rmin~d hy nicasuring [ ‘HIthy- 
midiw incorporatiol;into the acid insoluble fraction ot the cell\. In brief, 
cells \vere wcdcd at a densitv of 10” ct~lls/ml in Y6-w?ll plates (200 ~1 
RPM1 medium containing 10% FCS, Gihco, Eggenstcin, Germany), and 
incubated (37C, 5% COz) with Con A (0.1-10 fig/ ml, 48 h) in the precnct> 
or &sence of increasing concentrations of the NP (ANP, CNI’, C-ANF, 
10 ” -10 ” M) (n = h-12 each). Cells \\wt’ pulsed with [‘Hlthymidine 
(1 PCi /well, specific activity 25 Ci / mmol, Amersham, Br‘lunsch\vcig, 
Germany) for another 75 h. Following centrifugatlon (1200 rpm, IO min), 
the supernatant (150 ~1) \V~S wmovcd, and cells ww-c incuhatcd Ivith 50 
~1 20% trichloroacetic acid at 4C for 30 min before harvest on J glass fiber 
filter (ICN Biochemical, Mcckcnhcim, Germany) \vith ,m autohar\wtcl 
(Scatron, Norwav). Radioactivity incorporated \\‘a mc~asurcd in the 
presence of scintillation fluid. Experiments have bwn rcpeatcd at Ic*‘dst 
four times. 
Measurement of NP degradation 
Stability of peptide was assayed by incubating thymocytcs \vith 
‘?-labeled ANI’ and CNP (SO,000 cpm, specific actiwty 1000 Ci / mmol, 
Peninsula, Heidelberg, Germany), respectively, and the c~,rrc\ponding 
unlabeled peptide (10 nbf). Thymocytes \verc culturrd in the prtLst>ncc 
or absence of Con A as described above. Over the time courw of the 
experiment, supernatants (n = 3) wcrc’ collcctcd (0 h, I h, 2 h, IX h, 21 
h, and 18 h) and analyzed by reverse phase-HI’LC (23). Dt>gr~ldation of 
peptides during culture 1~~7s estimated hy counting radioactivIty of 
HPLC fractions and comparing the profile and amount of c*lutcd radio- 
acti\,ity with that of intact radiolaheled peptide. Stability of C-ANF 
(4-23) was aswved (n = 2) by measuring ‘1 given concentration of the 
peptide (I llM)‘in the medium after 2 h, _ 7-l h and 1X h incubation. 
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Following HPLC separation, C-ANF (4-23) positive fractions were 
quantified by a RIA previously described for ANP (23). 
Results 
Characterization and purity of thymocytes 
Special care was taken regarding isolation and purification 
of thymocytes. A high degree of purity of cells is mandatory 
because receptor mRNA expression of cells was planned to 
be examined by the sensitive technique of PCR. Small 
amounts of nonthymocytes could be responsible for false 
PCR results. Therefore, identity and homogeneity of each 
batch of thymocytes were always assessed by labeling cells 
with a monoclonal mouse antirat thymocyte antigen Thy 1.1 
antibody and subsequent analysis by flow cytometry. Figure 
1 shows a representative FACS histograph indicating that 
more than 98% of cells stained for the thymocyte marker. 
Expression of mRNA coding for NP receptors in rat 
thymocytes 
RT-PCR and Northern blot analysis were employed to 
detect NP receptor gene expression in thymocytes. The PCR 
amplification products were size-fractionated by PAGE elec- 
trophoresis and gels exposed to x-ray films. A representative 
autoradiography (Fig. 2A) shows that thymocytes express all 
three NP receptors: single bands of the expected size (451 bp 
Npra; 692 bp Nprb; 573 bp Nprc) were found. Transcripts of 
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FIG. 1. Analysis of purified thymocytes by flow cytometry using an 
antibody against rat thymocyte antigen Thy 1.1. A histogram of flu- 
orescence intensity us. counts for cells stained with the antibody is 
shown. Marker set around stained (M2) and unstained cells (Ml) 
allow determination of the number of thymocytes. For evaluation, the 
Lysis II FACScan software (Becton Dickinson) was used. 
A 
12345 
451 bp GC-A 
692 bp GC-B 
573 bp C-R 
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FIG. 2. A, Representative PCR of cDNA transcripts of NP-receptors 
in thymocytes. Corresponding amplification products were size frac- 
tionated by PAGE and exposed to x-ray films. Npra transcripts (451 
bp): lane 1, mRNA from thymocytes (10 ng); lane 2, thymocyte cDNA 
(10 ng); lane 3, thymus cDNA (10 ng); lane 4, kidney cDNA (1 ng); lane 
5, Npra transfected C-6 cells cDNA(0.5 ng). Nprb transcripts (692 bp): 
lane 1, mRNA from thymocytes (10 ng); lane 2, thymocytes cDNA (2 
ng); lane 3, thymus cDNA (10 ng); lane 4, kidney cDNA (1 ng); lane 
5, Nprb transfected C-6 cells cDNA (0.5 ng). Nprc (573 bp): lane 1, 
mRNA from thymocytes (20 ng); lane 2, thymocytes cDNA (20 ng); 
lane 3, thymus cDNA (20 ng); lane 4, kidney cDNA (5 ng). B, Auto- 
radiograph of representative Northern blot of poly(A+) RNA from 
thymocytes (T, corresponding to 100 pg total RNA) and lung (L, 30 pg 
total RNA). RNA was loaded on a 1% agarose gel, transferred to a 
nylon membrane, and hybridized separately with [32P1a-UTP-labeled 
cRNA probes for the Npra, Nprb, or Nprc. Films have been developed 
after 6 days of exposure time except for the last lane at the right side, 
which has been exposed for 12 days. 
kidney known to all three NP receptors (14,15,19,30). cDNA 
from cells transfected with either the Npra or Nprb sequence 
served as another positive control. For comparison, cDNA 
from whole thymus tissue was also employed to PCR con- 
firming previous data. To control for contamination, mRNA 
of cells without RT was amplified and did not yield any PCR 
products. 
PCR data were confirmed by Northern blot analysis of 
purified mRNA from thymocytes. Hybridization of thymo- 
cytes mRNA with radiolabeled Npr cRNA probes yielded a 
faint hybridization band of approximately 4.5-kb for the 
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Npra and Nprb mRNA, which comigrates with control 
mRNA extracted from lung. The Nprc transcript in lung 
tissue shows considerable size heterogenity. Two major 
bands at approximately 8 kb and 3.5 kb were detected. Thy- 
mocyte mRNA elicits the corresponding hybridization bands 
at a very low level (Fig. 2B). 
Stimulation of cGMP in rat thymocytes by ANP and CNP 
To look for the presence of functional receptor proteins on 
thymocytes, NP-stimulated cGMP accumulation was as- 
sayed. As shown in Fig. 3, exposure of cells to ANP signif- 
icantly increased cGMP concentration up to 3-fold at con- 
centrations of 10p7 M and lo-” M. CNP (10 ’ M) elicited an 
about 2-fold stimulation of cGMP production. C-ANF (4-23) 
at concentrations of lo-“-lo-’ M did not alter cGMP con- 
centration; however, lo-” M of C-ANF (4-23) elicited a ten- 
dency to increase cGMP accumulation (up to 15%). C-6 gli- 
oma cells transfected with cDNA of Npra and Nprb, 
respectively, served as positive controls. ANP stimulated 
cGMP accumulation in these cells at concentrations as low as 
1 nM, whereas 100 IlM of ANP is necessary to see significant 
effects on thymocytes. This could be explained by a lower 
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FIG. 3. cGMP responses to ANP (A) or CNP (B) in thymocytes. 
Freshly isolated thymocytes (Thy) were treated with increasing 
amounts of either ANP oE CNP for 1 h in the presence of the phos- 
ohodiesterase inhibitor IBMX (0.5 mM). In addition. C-ANF (lOm”hf) 
was tested. As positive control, C-6 glioma cells transfected either 
with Npra cDNA (panel A, Glio A) or with Nprb cDNA (panel B, Glio 
B) were treated in the same manner. cGMP concentration in the 
culture medium was determined by RIA. Data are mean + SD, n = 
3-4; ‘/‘, P < 0.05; t test. 
transfected cells. Subsequently, the magnitude of increase in 
cGMP is lower in thymocytes as compared to the transfected 
cells. Thus, ANP at 1 nM concentration might not elicit a 
sufficient cGMP response to exceed the threshold of basal 
cGMP production. 
To prove that cGMP production derives from activation of 
particulate guanylate cyclase, i.t,. the NI’ receptors, enzyme 
activity was also determined in thymocyte membrane prep- 
arations showing similar results (data not shown). 
Effect of Con A stimulation of thymocytes on Npr-mRNA 
expression 
mRNA of either freshly isolated cells, of cells that had been 
cultured for 48 h, or of cells exposed to Con A (48 h) were 
used for PCR-analysis of Npr specific transcripts. In order to 
compare corresponding mRNA levels, PCR conditions that 
allow relative quantitation of PCR products had to be es- 
tablished: 1) efficiency of the RT was determined by incor- 
poration of radioactive labeled dCTP and was shown to vary 
considerably (up to 100%). Consecutively, cDNA contents of 
samples were equalized. Furthermore, PCR amplification of 
mRNA coding for the house keeping gene GAPDH was 
performed with each cDNA preparation in order to note 
differences in cDNA concentrations (Fig. 4). 2) Each PCR 
reaction has been checked to remain in the exponential phase 
determining the appropriate range of initial amount of tem- 
plate at a constant number of cycles (i.c. 30). Equal efficiencies 
of amplification of NP transcripts in the three different cell 
preparations were demonstrated by parallelity of dose 
curves (as seen in Fig. 5). 
Figure 4 shows a representative experiment performed 
with three different amounts of initial cDNA subjected in 
triplicates to PCR for the Npra, Nprb, and Nprc. Bands were 
cut and incorporated radioactivity was blotted as a function 
of initial amount of cDNA. 
Figure 5 summarizes the results of three independent ex- 
periments. Interestingly, stimulation of thymocytes with the 
lectin Con A (1 pg/ml) leads to an about 4-fold increase of 
mRNA expression of the ANP specific NP receptor (Npra), 
whereas Nprb and Nprc expression was not markedly af- 
fected by incubation of cells with the mitogen. Apparently, 
keeping thymocyte in culture itself results in a somewhat 
higher Npra mRNA concentration (15fold) as compared 
with freshly isolated cells. 
GC-A Gc- B C-R GAPDH 
native 
,_- ---___ d-1 --- - 
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FIG. 4. Representative autoradiographs of PCR transcripts for the 
Npra, Nprb, and Nprc in freshly isolated thymocytes (native), in 
thymocytes cultured for 48 h (cultured) and in cells stimulated with 
Con A (1 Kg/ml) (Con A) for 48 h. Three different concentrations of 
initial cDNA, each in triplicates, were subjected to the corresponding 
PCR. PCR of GAPDH transcripts was performed to control for similar 
initial cDNA content of samples. Amplification products were sepa- 
rated by PAGE, and incorporated radioactivity was counted. 
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FIG. 5. Graphic line of incorporated radioactivity (cpm) of PCR amplification products blotted against the amount of initial cDNA. Levels of 
Npra, Nprb, and Nprc transcripts in native (01, cultured (a), and Con A(m) stimulated thymocytes are indicated by the amount of incorporated 
radioactivity (cpm) as described in Materials and Methods. Each value represents the mean of three independent experiments (tsu) run in 
triplicates. 
NP-induced cGMP production of thymocytes upon 
cultivation and lectin exposure 
A 2-day culture of thymocytes with Con A (1 pg/ml) 
resulted in an about 3-fold augmented cGMP accumulation 
upon treatment of cells with ANP (lop6 M) in comparison 
with native cells exposed to the same concentration of ANP. 
As shown in Fig. 6A, the activation is dose dependent (P < 
0.05; lo-” ~-10~” M). Basal cGMP production was slightly 
higher in cultured thymocytes as well as in stimulated cells 
than in freshly isolated thymocytes. Thus, when related to 
cGMP production of cells kept in culture, the ANP-induced 
guanylate cyclase activity of thymocytes treated with Con A 
was increased about 2-fold. 
In contrast, no significant increase in cGMP production 
was seen in cultured nor in stimulated thymocytes after 
exposure to CNP (Fig. 6B). Stability of AN!? and CNP over 
I-h incubation was evaluated by adding radiolabeled pep- 
tides and was shown to be approximately the same (i.e. less 
than 5% degradation). 
Effect of NP on rHlthymidine incorporation of thymocytes 
Apparently, stimulation of cell proliferation causes altered 
receptor expression for NP. Therefore, we examined whether 
the NP regulate proliferation of thymocytes by determining 
[“Hlthymidine incorporation. Thymocytes were stimulated 
with 1 pg/ml Con A, a concentration which has been pre- 
viously shown to elicit submaximal proliferation of cells 
(data not shown). As shown in Fig. 7A, addition of ANP at 
concentrations of 10 ~-’ ~-lo- ’ M, significantly inhibited mi- 
togen-stimulated thymidine incorporation. Proliferation of 
cells that had not been exposed to Con A was not altered by 
ANP (data not shown). ANP (lOPh M) inhibited Con A in- 
duced cell growth by a mean of 50%, as calculated from six 
independent experiments set up with n = 12 samples for each 
treatment. CNP, however, did not share the inhibitory prop- 
erties of ANP. C-ANF, a specific ligand of the Nprc receptor, 
was also not able to mimic the effect of ANP, suggesting that 
the suppression was mediated via the Npra receptor. Sta- 
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FIG. 6. cGMP production of native thymocytes, cultured (48 h), and 
Con A-stimulated cells. Each batch of cells was exposed to increasing 
concentration of either ANP (A) or CNP (B) for 1 h in the presence of 
0.5 mM IBMX. cGMP concentration in the medium was determined by 
RIA. CN means basal cGMP production. Values represent mean -t SD, 
n = 3-4. <‘, P < 0.05 compared with the corresponding basal value 
(CN), #, P < 0.05 compared with the corresponding treatment of cells, 
t test. 
bility of the three peptides over the time course of the ex- 
periments was evaluated as described in Mnterinls and Mefh- 
ods. The rates of degradation of the peptides are in a 
comparable range, although CNP seems to be less stable than 
ANP after an incubation time of 18 h and more. Degradation 
(expressed as % of intact NP) after 18 h amounts to about 30% 
GROWTH INHIBITION OF THYMOCYTES BY ANP 1711 
FIG. 7. Effects of NP on Con A-stimu- 
lated incorporation of [“Hlthymidine in 
thymocytes. Cells (2 x lO”/well) were 
treated with Con A (1 fig/ml, 48 h) with 
or without decreasing concentrations 
(10 6~-10 “iv~)ofANP(panelA),CNP 
(panel B), and C-ANF (panel CL Thy- 
mocytes were then pulsed with [“Hlthy- 
midine (1 @J/well) for another 15 h. 
Values are normalized to levels found in 
Con A-stimulated cells (100%) and are 
given as means + SD, n = 6-12. *, P < 
0.05, t test. Each experiment was per- 




for ANP and 46% for CNP. After 24 h of incubation, 50% of 
ANP, 69% of CNP, and 57% of C-ANF were found to be 
degraded. Finally 63% of ANP, 81% of CNP, and 75% of 
C-ANF had been lost after a 48-h exposure to the cells. 
Discussion 
We have previously shown that ANP, BNP, and CNP, 
peptides mainly known for their distinct effects in the car- 
diovascular system, are coexpressed in rat thymus (10, 11). 
The fact that the three NP receptors, namely Npra, Nprb, and 
Nprc, seemed also to be present in the thymus prompted the 
question of a function for this local thymic natriuretic peptide 
system (11). The present study represents a step-by-step ap- 
proach towards this question. We found that: 
1) Thymocytes have been identified as a possible popu- 
lation of target cells for NP. mRNAs of the three NP 
receptors were detected in isolated thymocytes by RT- 
PCR as well as by Northern blot and presence of func- 
tional Npra and Nprb receptors was demonstrated by 
increased cGMP production upon exposure of cells to 
NP. 
2) Expression of NP receptors is differentially modulated 
by cell activation. Thymocytes stimulated with Con A 
express higher concentrations of mRNA coding for 
Npra as well as increased guanylate cyclase activity 
upon ANP exposure. Nprb and Nprc seemed not to be 
affected by Con A. 
3) ANP inhibits cell proliferation of Con A-activated thy- 
mocytes, whereas CNP and C-ANF do not show this 
effect. 
This is the first study describing an effect for endogenous 
ANP on the thymus. Binding sites for ANP in thymus and 
thymocytes, however, have been reported before (31, and J. 
Gutkowska, Montreal, personal communication). However, 
at that time the existence of different NP receptor subtypes 
as well as the existence of two other NP had not been elu- 
cidated yet. 
NP receptors have been reported on bone marrow derived 
stromal cells (32), and the authors discussed that ANP re- 
ceptors might be also localized on thymic stromal cells. Thus, 
7 8 9 10 11 6 7 8 9 10 11 6 7 8 9 10 11 
Con A + Con A Con A + Con A Con A + 
ANP -log (M) CNP -log (M) C-ANF -log (M) 
in addition to thymocytes, other thymic cells could express 
receptors for NP. Therefore, we paid special attention to the 
degree of purity of cells subjected to mRNA analysis by 
RT-PCR. 
With regard to the relative distribution of the three NP 
receptors, the Nprb seems to be preferentially expressed on 
thymocytes. This assumption is based on the low amounts of 
thymocyte cDNA necessary to obtain a PCR signal in com- 
parison with whole thymus tissue. Furthermore, Nprb ex- 
pression may also exceed that of Npra and Nprc on thymo- 
cytes. An exact analysis of degree of Npr expression, 
however, requires absolute quantification of PCR products, 
which cannot be achieved using our PCR protocol. 
This observation at the mRNA level is not reflected by the 
functional data of Npr expression, i.e. stimulation of cGMP 
production: ANP was more effective than CNP in stimulat- 
ing guanylate cyclase-activity of thymocytes. Similar dis- 
crepancies have been reported by others (33-36). It is very 
difficult to speculate about the relationship between the 
amount of mRNA level and the number and activity of re- 
ceptors present on the cell surface. Translational processes 
may be different between Npra and Nprb receptors, i.c. the 
rate of translation as well as the stability of the protein, may 
be lower in the case of the Nprb. Alternatively, the catalytic 
activity of the two receptors might differ as was previously 
suggested (33-36). Finally, CNP might not be the most potent 
ligand for the Nprb or thymocytes express a Nprb subtype 
with different ligand specificity. Moreover, the two receptors 
may mediate different functions (34). This latter notion is 
supported by the observations reported here, namely that the 
expression of Npr underlies different regulatory mechanism. 
The Npra, but not the Nprb and Nprc, are up-regulated in 
response to activation of cells with a mitogen. Subjecting cells 
to ifz z&o culture itself increased Npra expression. The in- 
crease, however, was modest in comparison with that in- 
duced by Con A. In this context, subtype switching of ANP 
receptors has been recently described for chondrocytes and 
aortic smooth muscle cells during culture (37,38). The mech- 
anism underlying such alteration of receptor distribution 
remains to be elucidated. 
One may speculate that an increased expression of recep- 
tors represents a mechanism rendering the cells more sen- 
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sitive for an effect of the corresponding l&and. The fact that 
exposure of cells to the mitogen Con A increases Npra re- 
ceptor mRNA expression supports a possible relationship 
between ANP/Npra mediated interaction and thymocyte 
activation. Indeed, ANP was shown to inhibit thymocyte 
proliferation induced by Con A. However, there is an ap- 
parent lack of correlation between the dose response curve 
for ANP stimulation of cGMP production and growth inhi- 
bition. A concentration of lo-100 nM ANP was necessary to 
elicit a significant increase of cGMP accumulation. These 
concentrations are in the range of those reported for bone 
marrow-derived stromal cells, aortic smooth muscle cells, or 
uterus tissue (32, 33, 35, 39). In contrast, ANP at concentra- 
tions as low as 1 IIM significantly blocked proliferation of Con 
A-stimulated thymocytes. This kind of discrepancy has pre- 
viously been reported for vascular smooth muscle cells (33). 
As mentioned by Porter ~‘f 171. (33), submaximal levels of 
cGMP may be sufficient to inhibit growth. 
NP have been shown before to be able to interfere with cell 
growth: an antimitogenic function of the peptides has been 
reported for other cell types such as cardiac fibroblasts (40), 
glia cells (41), endothelial (42), and vascular smooth muscle 
cells (33,39,43). The observation that CNP did not show any 
antigrowth effect on thymocytes in contrast to other cells (33, 
39-41) was surprising. Degradation of CNP over the time of 
the experiment was 20-30% higher than that of ANP. How- 
ever, this difference in stability is unlikely to account for the 
lack of effect on thymocyte proliferation by CNP because 
ANP is active over a three-log range of concentrations. The 
lack of response may be rather explained by the missing 
stimulation of Nprb, the specific receptor of CNP, by Con A. 
Regarding the NP-receptor type that mediates the anti- 
proliferative effect, both the guanylate cyclase coupled and 
the Nprc receptors have been reported to be responsible 
(39-43). Increased Npra upon Con A incubation and, more- 
over, the lack of effect of C-ANF, the specific Nprc-receptor 
ligand on thymocyte thymidine incorporation, suggest the 
guanylate cyclase linked receptor to promote this effect. 
Primary thymocytes represent a highly heterogeneous cell 
population (44). In this context, it is worth mentioning that 
Con A at a concentration of 1 PLg / ml induces only submaxi- 
mal level of cell proliferation (data not shown), and there is 
evidence that lower concentrations of Con A preferentially 
activate CD4 T-lymphocytes (45). Thus, most likely only a 
part of the total thymocytes responds to Con A and subse- 
quently to ANP. CD4 positive thymocytes may be the main 
target cells for ANP, and the peptide should elicit a quite 
significant effect on the basis of single responsive cells. Elu- 
cidation of the exact cell type bearing NP receptors will be 
helpful to find a distinct role for ANP in the thymus. Thy- 
mocytes proceed through distinct stages of proliferation and 
differentiation: for instance, thymocyte precursors rapidly 
proliferate and then cease proliferation to go through mat- 
uration and selection processes (44). ANP might inhibit thy- 
mocyte proliferation to allow differentiation to occur. Similar 
roles have been proposed for met-enkephalin-containing 
peptides in the thymus (46) and for a variety of other neu- 
ropeptides such as OT and AVP (47) as well as PRL (48). 
In conclusion, we have demonstrated an effect of endog- 
enous atria1 natriuretic peptide on thymocyte proliferation. 
This effect seems to be mediated by the Npra receptor, which 
was shown to be up-regulated following stimulation with 
Con A. The functional significance of thymic CNP, however, 
remains to be elucidated. The data suggest that endogenous 
natriuretic peptides affect thymus physiology in a similar 
manner as cytokines or growth factors. This is a novel aspect 
in the biology of natriuretic peptides. 
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